… It can be triggered by various therapies, autoimmune … , and a case-based approach, this
chapter provides critical … nanoparticles can be a novel therapeutic approach for the treatment of …

… release syndrome (CRS) [172], its targeting with anti-IL-6R monoclonal antibodies (eg,
tocilizumab, sarilumab, siltuximab) is of main interest for therapeutic approach. In this regard, …

… 2, the approach assumes that all cytokine storms are the same … of the pathogenic cytokines
in CRS, IL-6, with Tocilizumab … first- and second-line therapies for cytokine storm induced by …

… therapies and monoclonal antibodies cause cytokine release syndrome. Efforts are being
carried out to maximize the chance for therapeutic … on the inflammatory cytokine storm and its …

… Furthermore, cytokine storm can cause post-COVID-19 … in COVID-19-related cytokine storm
and its association with multi-… potential therapeutic targets to control cytokine storm wishing …

… to manage the several complications caused by an intense release of cytokines. This paper
reviews the current options on drugs used to reduce the deadly effects of the cytokine storm. …

… The immunomodulatory effect of the SCD in the excessive inflammatory state and cytokine
storm differs from other current approaches to treat this dysregulated immunologic state. …

… cytokine levels while discussing cytokine sources and biological functions. Finally, we discuss
in brief potential therapies attempting to modulate the cytokine storm… therapeutic approach …

… Disruption of the CCL-5-CCR5 axis therefore seems an attractive therapeutic approach. An
open-label study (phase 2) is currently ongoing to establish whether one week of treatment …

… of SARS-CoV-2, prevent disease progression and modulate the cytokine storm in COVID-19. …
approach to ratchet down the virulence of SARS-CoV-2 and modulate the cytokine storm in …